Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia–reperfusion
- 4 April 2006
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 78 (19), 2255-2264
- https://doi.org/10.1016/j.lfs.2005.09.053
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor κB and caspase-3Life Sciences, 2005
- Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1Cardiovascular Research, 2005
- An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotectionCardiovascular Research, 2004
- Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal ApoptosisThe Journal of Experimental Medicine, 2003
- Preconditioning with erythropoietin protects against subsequent ischemia‐reperfusion injury in rat kidneyThe FASEB Journal, 2003
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003
- Activation of the transcription factor NF-κB by the erythropoietin receptor: Structural requirements and biological significanceCellular Signalling, 2001
- Ischemic Preconditioning and Lipopolysaccharide Attenuate Nuclear Factor-.KAPPA.B Activation and Gene Expression of Inflammatory Cytokines in the Ischemia-Reperfused Rat Heart.Japanese Circulation Journal, 2001
- An essential role for NF-κB in the cardioadaptive response to ischemiaThe Annals of Thoracic Surgery, 1999
- The Influence of Recombinant Human Erythropoietin on Tumor Necrosis Factor α and Interleukin‐10 Production by Whole Blood Cell Cultures in Hemodialysis PatientsArtificial Organs, 1998